Global burden of early-onset colorectal cancer among people aged 40–49 years from 1990 to 2019 and predictions to 2030.

Purpose: To explore the disease burden of early-onset colorectal cancer (EO-CRC) in individuals aged 40–49 years and provide baseline evidence for routine recommended age adjustment for CRC screening and other clinical decision-making. Methods: We collected data stratified by sex, risk factors, and socio-demographic index (SDI) from the Global Burden of Disease Study 2019 Data Resources. Trends in disease burden were analyzed by estimated annual percentage change. The Bayesian age-period-cohort model predicted the burden over the following 10 years. Results: In 2019, the global rates of incidence, mortality, prevalence, and disability-adjusted life year (DALY) of EO-CRC in people aged 40–44 years were 11.48 (95% uncertainty interval: 10.50–12.59), 4.35 (4.01–4.70), 72.63 (66.48–79.52), 209.82 (193.55–226.59) per 100,000 population. For people aged 45–49 years, the rates of these four estimates were 19.63 (17.97–21.54), 7.76 (7.16–8.41), 121.73 (110.99–133.84), and 335.83 (310.14–362.91), respectively. The incidence and prevalence rates for both age groups increased while the mortality and DALY rates remained stable from 1990 to 2019. In 2019, high-income North America had the highest incidence and prevalence rates. A low milk diet accounted for the largest proportion of global DALYs in EO-CRC, and there was a tendency for the DALY rate first to increase and then decrease with increasing SDI. The incidence and mortality rates were predicted to increase in the next 10 years. Conclusion: The current and future burden of EO-CRC among people aged 40–49 years is heavy. Substantial variation exists in disease burden across regions and countries. Urgent screening actions and policies are needed. [ABSTRACT FROM AUTHOR]